P158 PONDx Aragon: First spanish prospective study evaluating the impact of the 21-gene test on real praxis for N1 patients after RxPONDER results von Andres, R., Hernandez, A., Fernandez, A., Comin, A., Nuño, A., Aguirre, E., Arevalo, E., Millastre, E., Alvarez, I., Verdun, J.A., Lao, J., Murillo, L., Galan, N., Bueso, P., Puertolas, T., Hagen, C., Inglada-Perez, L., Anton, A.

Volltext

EBANO study: real-world data from patients with locally advanced/metastatic urothelial carcinoma (la/mUC) in Northern Spain von Fernández Rodríguez, R., Sagastibeltza, N., Pujol Obis, E., Lainez Milagro, N., Sánchez-Escribano, R., Martínez Kareaga, M., Verdún Aguilar, J.A., Arruti Ibarbia, M., Pumares González, M., de Portugal Fernández del Rivero, T., Lacalle Emborujo, A., Gil Arnaiz, I., Pereira-Elorrieta, A., Álvarez Fernández, C., Duran, I.

Volltext

Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma von Park, Hyung, Tarpey, Thaddeus, Liu, Mengling, Goldfeld, Keith, Wu, Yinxiang, Wu, Danni, Li, Yi, Zhang, Jinchun, Ganguly, Dipyaman, Ray, Yogiraj, Paul, Shekhar Ranjan, Bhattacharya, Prasun, Belov, Artur, Huang, Yin, Villa, Carlos, Forshee, Richard, Verdun, Nicole C, Yoon, Hyun Ah, Agarwal, Anup, Simonovich, Ventura Alejandro, Scibona, Paula, Burgos Pratx, Leandro, Belloso, Waldo, Avendaño-Solá, Cristina, Bar, Katharine J, Duarte, Rafael F, Hsue, Priscilla Y, Luetkemeyer, Anne F, Meyfroidt, Geert, Nicola, André M, Mukherjee, Aparna, Ortigoza, Mila B, Pirofski, Liise-Anne, Rijnders, Bart J A, Troxel, Andrea, Antman, Elliott M, Petkova, Eva

Volltext